Inflammatory mediators, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), can reach brain tissue and influence the development of depression and sleep disorders by modulating synaptic transmission, neuronal excitability, neuronal survival, and synaptic plasticity (29, 30). Here, TNF is linked to depressive symptom measurement.